Number of the records: 1
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis
- Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis / Ryan C. ... [et al.]. Dermatológia pre prax Roč. 12, č. 3 (2018), s. 147
article
Number of the records: 1